Antiviral Effect of Natural and Semisynthetic Diterpenoids against Adenovirus Infection in vitro

Abstract

The emergence and re-emergence of viruses has highlighted the need to develop new broad-spectrum antivirals to mitigate human infections. Pursuing our search for new bioactive plant-derived molecules, we study several diterpene derivatives synthesized from jatropholones A and B and carnosic acid isolated from Jatropha isabellei and Rosmarinus officinalis, respectively. Here, we investigate the antiviral effect of the diterpenes against human adenovirus (HAdV-5) that causes several infections for which there is no approved antiviral therapy yet. Ten compounds are evaluated and none of them present cytotoxicity in A549 cells. Only compounds 2, 5 and 9 inhibit HAdV-5 replication in a concentration-dependent manner, without virucidal activity, whereas the antiviral action takes place after virus internalization. The expression of viral proteins E1A and Hexon is strongly inhibited by compounds 2 and 5 and, in a lesser degree, by compound 9. Since compounds 2, 5 and 9 prevent ERK activation, they might exert their antiviral action by interfering in the host cell functions required for virus replication. Besides, the compounds have an anti-inflammatory profile since they significantly inhibit the levels of IL-6 and IL-8 produced by THP-1 cells infected with HAdV-5 or with an adenoviral vector. In conclusion, diterpenes 2, 5 and 9 not only exert antiviral activity against adenovirus but also are able to restrain pro-inflammatory cytokines induced by the virus.

Key words

Jatropha isabellei - Rosmarinus officinalis. - diterpenes - antiviral - adenoviridae - Euphorbiaceae - Lamiaceae

Publication History

Received: 15 January 2023

Accepted after revision: 20 March 2023

Accepted Manuscript online:
20 March 2023

Article published online:
09 May 2023

• References

• 1 Ison MG, Hayden RT. Adenovirus. Microbiol Spectr 2016; 4: 1-14
• 2 Lion T. Adenovirus infections in immunocompetent and immunocompromised patients. Clin Microbiol Rev 2014; 27: 441-462
• 3 Mynarek M, Ganzenmueller T, Mueller-Heine A, Mielke C, Gonnermann A, Beier R, Sauer M, Eiz-Vesper B, Kohstall U, Sykora K, Heim A, Maecker-Kolhoff B. Patient, virus, and treatment-related risk factors in pediatric adenovirus infection after stem cell transplantation: Results of a routine monitoring program. Biol Blood Marrow Transplant 2014; 20: 250-256
• 4 Schilham MW, Claas EC, van Zaane W, Heemskerk B, Vossen JM, Lankester AC, Toes RE, Echavarria M, Kroes AC, van Tol MJ. High levels of adenovirus DNA in serum correlate with fatal outcome of adenovirus infection in children after allogeneic stem‐cell transplantation. Clin Infect Dis 2002; 35: 526-532
• 5 Lion T, Kosulin K, Landlinger C, Rauch M, Preuner S, Jugovic D, Pötschger U, Lawitschka A, Peters C, Fritsch G, Matthes-Martin S. Monitoring of adenovirus load in stool by real-time PCR permits early detection of impending invasive infection in patients after allogeneic stem cell transplantation. Leukemia 2010; 24: 706-714
• 6 Wold WSM, Toth K. New drug on the horizon for treating adenovirus. Expert Opin Pharmacother 2015; 16: 2095-2099
• 7 Grosso F, Stoilov P, Lingwood C, Brown M. Suppression of adenovirus replication by cardiotonic steroids. J Virol 2017; 91: 1-16
• 8 Labib BA, Minhas BK, Chigbu DI. Management of adenoviral keratoconjunctivitis: challenges and solutions. Clin Ophthalmol 2020; 14: 837-852
• 9 Piatti G. Pre-transplant screening for latent adenovirus in donors and recipients. Open Microbiol J 2016; 10: 4-11
• 10 Flaherty DM, Hinde SL, Monick MM, Powers LS, Bradford MA, Yarovinsky T, Hunninghake GW. Adenovirus vectors activate survival pathways in lung epithelial cells. Am J Physiol Lung Cell Mol Physiol 2004; 287: L393
• 11 Chen R, Lee C. Adenoviruses types, cell receptors and local innate cytokines in adenovirus infection. Int Rev Immunol 2013; 33: 1-9
• 12 Ali SI, Sheikh WM, Rather MA, Venkatesalu V, Bashir SM, Nabi SUI. Medicinal plants: Treasure for antiviral drug discovery. Phytother Res 2021; 35: 3447-3483
• 13 Alché LE, Barquero AA, Sanjuan NA, Coto CE. An antiviral principle present in a purified fraction from Melia azedarach L. leaf aqueous extract restrains Herpes simplex virus type 1 propagation. Phytother Res 2002; 16: 348-352
• 14 Petrera E, Coto CE. Effect of meliacine, a plant derived antiviral, on tumor necrosis factor alpha. Fitoterapia 2003; 74: 77-83
• 15 Petrera E, Coto CE. Therapeutic effect of Meliacine, an antiviral derived from Melia azedarach L, in mice genital herpetic infection. Phytother Res 2009; 23: 1771-1777
• 16 Petrera E. Antiviral and immunomodulatory properties of Meliaceae family. Journal of Biologically Active Products from Nature 2015; 5: 241-254
• 17 Alché LE, Ferek GA, Meo M, Coto CE, Maier MS. An antiviral meliacarpin from leaves of Melia azedarach L. Z Naturforsch C J Biosci 2003; 58: 215-219
• 18 Bueno CA, Barquero AA, Di Cónsoli H, Maier MS, Alché LE. A natural tetranortriterpenoid with immunomodulatory properties as a potential anti-HSV agent. Virus Res 2009; 141: 47-54
• 19 Bueno CA, Alché LE, Barquero A. A 1-Cinnamoyl-3, 11-di- hydroxymeliacarpin delays glycoprotein transport restraining virus multiplication without cytotoxicity. Biochem Biophys Res Commun 2010; 393: 32-37
• 20 Petrera E, Coto CE. Effect of the potent antiviral 1-cinnamoyl-3, 11-dihydroxymeliacarpin on cytokine production by murine macrophages stimulated with HSV-2. Phytother Res 2014; 28: 104-109
• 21 Petrera E, Coto CE. The synergistic effect of IFN-α and IFN-γ against HSV-2 replication in Vero cells is not interfered by the plant antiviral 1-cinnamoyl-3, 11-dihydroxymeliacarpin. Virol J 2006; 3: 45
• 22 Bueno CA, Lombardi MG, Sales ME, Alché LE. A natural antiviral and immunomodulatory compound with antiangiogenic properties. Microvasc Res 2012; 84: 235-241
• 23 Pertino M, Schmeda-Hirschmann G, Rodríguez JA, Theoduloz C. Gastroprotective effect and cytotoxicity of semisynthetic jatropholone derivatives. Planta Med 2007; 73: 1095-1100
• 24 Pertino M, Schmeda-Hirschmann G, Rodríguez JA, Theoduloz C. Gastroprotective effect and cytotoxicity of terpenes from the Paraguayan crude drug “yagua rova” (Jatropha isabelli). J Ethnopharmacol 2007; 111: 553-559
• 25 Theoduloz C, Rodríguez JA, Pertino M, Schmeda-Hirschmann G. Antiproliferative activity of the diterpenes jatrophone and jatropholone and their derivatives. Planta Med 2007; 73: 1520-1522
• 26 Pertino MW, Theoduloz C, Rodríguez JA, Yáñez T, Lazo V, Schmeda-Hirschmann G. Gastroprotective effect of carnosic acid γ-lactone derivatives. J Nat Prod 2010; 73: 639-643
• 27 Bueno CA, Michelini FM, Pertino MW, Arredondo GC, Schmeda-Hirschmann G, Alché LE. Natural and semisynthetic diterpenoids with antiviral and immunomodulatory activities block the ERK signaling pathway. Med Microbiol Immunol 2015; 204: 575-584
• 28 Lenaerts L, Naesens L. Antiviral therapy for adenovirus infections. Antiviral Res 2006; 71: 172-180
• 29 Jennings MR, Parks RJ. Antiviral effects of curcumin on adenovirus replication. Microorganisms 2020; 8: 1524
• 30 Mazzotta S, Berastegui-Cabrera J, Vega-Holm M, García-Lozano MR, Carretero-Ledesma M, Aiello F, Vega-Pérez JM, Pachón J, Iglesias-Guerra F, Sanchez-Céspedes J. Design, synthesis and in vitro biological evaluation of a novel class of anti-adenovirus agents based on 3-amino-1, 2-propanediol. Bioorg Chem 2021; 114: 105095
• 31 Qiu B, Wei F, Su J, Hao W, Zhou J, Zhao J, Wang Y, Qu Z. The effects of β-Pinene, a pine needle oil monoterpene, on adenovirus type 3. Bull Exp Biol Med 2022; 172: 345-351
• 32 Nikitenko NA, Gureeva ES, Ozerov AA, Tukhvatulin AI, Izhaeva FM, Prassolov VS, Deryabin PG, Novikov MS, Logunov DY. 1-(4-Phenoxybenzyl) 5-aminouracil derivatives and their analogues–novel inhibitors of human adenovirus replication. Acta Naturae 2018; 37: 58-64
• 33 Xu J, Berastegui-Cabrera J, Chen H, Pachón J, Zhou J, Sanchez-Céspedes J. Structure−activity relationship studies on diversified salicylamide derivatives as potent inhibitors of human adenovirus infection. J Med Chem 2020; 63: 3142-3160
• 34 Verma A, Vimalesvaran S, Lampejo T, Deep A, Dhawan A. Use of cidofovir in recent outbreak of adenovirus-associated acute liver failure in children. Lancet Gastroenterol Hepatol 2022; 7: 700-702
• 35 Theoduloz C, Pertino MW, Rodríguez JA, Schmeda-Hirschmann G. Gastroprotective effect and cytotoxicity of carnosic acid derivatives. Planta Med 2011; 77: 882-887
• 36 Bruder JT, Kovesdi I. Adenovirus infection stimulates the Raf/MAPK signaling pathway interleukin-8 expression. J Virol 1997; 71: 398-404
• 37 Schümann M, Dobbelstein M. Adenovirus-induced extracellular signal-regulated kinase phosphorylation during the late phase of infection enhances viral protein levels and virus progeny. Cancer Res 2006; 66: 1282-1288
• 38 Booth JL, Coggeshall KM, Gordon BE, Metcalf JP. Adenovirus type 7 induces interleukin-8 in a lung slice model and requires activation of Erk. J Virol 2004; 78: 4156-4164
• 39 Zhu J, Meng W, Wang X, Wang HR. Broad-spectrum antiviral agents. Front Microbiol 2015; 6: 517
• 40 Planz O. Development of cellular signaling pathway inhibitors as new antivirals against influenza. Antiviral Res 2013; 98: 457-468
• 41 Cavalcante NB, Diego da Conceição Santos A, Guedes da Silva Almeida JR. The genus Jatropha (Euphorbiaceae): A review on secondary chemical metabolites and biological aspects. Chem Biol Interact 2020; 318: 108976
• 42 Fattahian M, Ghanadian M, Ali Z, Khan IA. Jatrophane and rearranged jatrophane-type diterpenes: Biogenesis, structure, isolation, biological activity and SARs (1984–2019). Phytochem Rev 2020; 19: 265-336
• 43 Li K, Xu Y, Yue W. Anti-viral activity of jatrophone against RSV-induced respiratory infection via increase in interferon-γ generating dendritic cells. Environ Toxicol 2020; 35: 888-894
• 44 González-Cardenete MA, Hamulić D, Miquel-Leal FJ, González-Zapata N, Jimenez-Jarava OJ, Brand YM, Restrepo-Mendez LC, Martinez-Gutierrez M, Betancur-Galvis LA, Marín ML. Antiviral profiling of C-18- or C-19-functionalized semisynthetic Abietane diterpenoids. J Nat Prod 2022; 85: 2044-2051